<DOC>
	<DOCNO>NCT00137605</DOCNO>
	<brief_summary>The purpose study determine whether people HIV-positive respond well vaccine pneumonia-related disease immunize immediately , immunization delay immune system improve certain level . The study also compare effectiveness polysaccharide heptavalent vaccine .</brief_summary>
	<brief_title>Early Versus Delayed Pneumococcal Vaccination HIV</brief_title>
	<detailed_description>A multicentre , randomize control trial use two factorial design . Eighty patient randomly assign receive either Pneumovax ( Pneumo23 accord standard use site ) heptavalent pneumococcal conjugate vaccine ( Prevnar ) prior reconstitution immune system immunization delay CD4 count great 200 cells/mm3 introduction antiretroviral therapy . Randomization stratify study centre . Variable block size use try prevent study personnel guess next allocation . Random allocation list generate computer .</detailed_description>
	<mesh_term>Pneumococcal Infections</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>HIVpositive Between 18 65 year age Have CD4 cell count 200 cells/mm3 Willing begin/change antiretroviral therapy Willing able provide inform consent Pregnant breastfeeding Have previous pneumococcal vaccination Have occurrence pneumococcal infection ( brain , blood lung infection ) past 5 year Have hypersensitivity component either vaccine Have acute feverish illness time vaccination Have splenectomy ( removal spleen ) Have receive treatment IVIG within last 6 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>HIV</keyword>
	<keyword>HIV Infections</keyword>
</DOC>